Combining Radiotherapy with SOC Plus Abiraterone Improves rPFS in Patients with Low-Volume de Novo Metastatic Castration-Sensitive Prostate Cancer By Ogkologos - December 5, 2024 601 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-1 study Source RELATED ARTICLESMORE FROM AUTHOR High HPV Vaccination Coverage in England Associated with a Substantial Reduction in Cervical Cancer Mortality FDA Approves Datopotamab Deruxtecan-dlnk for Unresectable or Metastatic TNBC Oral Sunvozertinib Prolongs PFS Over Chemotherapy as First-Line Treatment for Patients with Advanced NSCLC with EGFR Exon 20 Insertions MOST POPULAR New Generation of Antibody-Drug Conjugates (ADCs) Shows Unprecedented Promise in Early-Stage... October 18, 2025 Adding Relacorilant To Nab-paclitaxel Prolongs Survival Compared with a Weekly Taxane... June 23, 2025 OS Advantage of Gotistobart Over Docetaxel in Patients with anti-PD‑(L)1- and... April 14, 2026 How Running and Training for a Marathon Helped Me Cope After... August 22, 2023 Load more HOT NEWS HER2 Expression is a Determinant of Sensitivity to Trastuzumab Deruxtecan in... How the Cancer Community Can Help Close the Care Gap This... EMA Recommends Granting a Marketing Authorisation for Generic Abiraterone for the... Treatment with Tebentafusp Results in Longer Overall Survival Among Previously Untreated...
